Company Filing History:
Years Active: 2009
Title: David C Greenberg: Innovator in Neurogenerative Research
Introduction
David C Greenberg is a prominent inventor based in Sonoma, California. He has made significant contributions to the field of neurogenerative research, particularly in the area of mitigating symptoms of ischemia. His work focuses on the identification of factors that can enhance the migration and differentiation of stem cells into neurons.
Latest Patents
David C Greenberg holds a patent for "Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia." This invention pertains to the identification of neurogenerative and/or neurotrophic factors that can induce migration of stem cells to neural tissue and/or induce proliferation and/or differentiation of such cells into neurons. The agents identified in this patent include stem cell factor (SCF), heparin binding EGF (HB-EGF), and VEGF.
Career Highlights
David is associated with the Buck Institute for Age Research, where he conducts his research and development activities. His work has been instrumental in advancing our understanding of neurodegenerative conditions and potential therapeutic approaches.
Collaborations
David has collaborated with notable colleagues, including Kunlin Jin and Xiao Ou Mao, to further explore the applications of his research in neurobiology.
Conclusion
David C Greenberg's innovative work in neurogenerative factors represents a significant advancement in the field of neuroscience. His contributions have the potential to impact the treatment of ischemic conditions and enhance our understanding of stem cell biology.